Cancer biopsy market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 157 Category: Pharma & Healthcare Report Code : HC0114858
Cancer biopsy market By Type (Instruments, Kits & Consumables, Services) and Application (Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers,Ovarian Cancers, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Cancer biopsy market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Cancer biopsies are performed on an outpatient basis with minimal preparation. It involves the removal of tissue from any part of the body to examine it for disease.Biopsies are performed in several different ways. Some biopsies involve removing a small amount of tissue with a needle while others involve surgically removing an entire lump, or nodule.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Cancer biopsy market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Qiagen N.V.
- Illumina, Inc.
- ANGLE Plc
- BD (Becton, Dickinson And Company)
- Myriad Genetics
- Hologic, Inc.
- Biocept, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher
- F. Hoffmann-La Roche Ltd.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Cancer biopsy market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Instruments
o Kits & Consumables
o Services
· Cancer biopsy market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Breast Cancer
o Colorectal Cancer
o Cervical Cancer
o Lung Cancers
o Prostate Cancers
o Ovarian Cancers
o Others
· Cancer biopsy market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Qiagen N.V.
o Illumina, Inc.
o ANGLE Plc
o BD (Becton, Dickinson And Company)
o Myriad Genetics
o Hologic, Inc.
o Biocept, Inc.
o Thermo Fisher Scientific, Inc.
o Danaher
· Cancer biopsy market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Cancer biopsy market, By Country
o U.S. Cancer biopsy market
o Canada Cancer biopsy market
o Mexico Cancer biopsy market
o Europe
§ Europe Cancer biopsy market, By Country
o UK Cancer biopsy market
o Germany Cancer biopsy market
o France Cancer biopsy market
o Russia Cancer biopsy market
o Italy Cancer biopsy market
o Rest of Europe Cancer biopsy market
o Asia-Pacific
§ Asia-Pacific Cancer biopsy market, By Country
o China Cancer biopsy market
o Japan Cancer biopsy market
o South Korea Cancer biopsy market
o India Cancer biopsy market
o Southeast Asia Cancer biopsy market
o Rest of Asia-Pacific Cancer biopsy market
o South America
§ South America Cancer biopsy market
o Brazil Cancer biopsy market
o Argentina Cancer biopsy market
o Columbia Cancer biopsy market
o Rest of South America Cancer biopsy market
o Middle East and Africa
§ Middle East and Africa Cancer biopsy market
o Saudi Arabia Cancer biopsy market
o UAE Cancer biopsy market
o Egypt Cancer biopsy market
o Nigeria Cancer biopsy market
o South Africa Cancer biopsy market
o TurkeyCancer biopsy market
o Rest of MEA Cancer biopsy market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Cancer Biopsy Market, By Type
5.1. Introduction
5.2. Global Cancer Biopsy Revenue and Market Share by Type (2017-2021)
5.2.1. Global Cancer Biopsy Revenue and Revenue Share by Type (2017-2021)
5.3. Instruments
5.3.1. Global Instruments Revenue and Growth Rate (2017-2021)
5.4. Kits & Consumables
5.4.1. Global Kits & Consumables Revenue and Growth Rate (2017-2021)
5.5. Services
5.5.1. Global Services Revenue and Growth Rate (2017-2021)
6. Cancer Biopsy Market, By Applications
6.1. Introduction
6.2. Global Cancer Biopsy Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Cancer Biopsy Revenue and Revenue Share by Applications (2017-2021)
6.3. Breast Cancer
6.3.1. Global Breast Cancer Revenue and Growth Rate (2017-2021)
6.4. Colorectal Cancer
6.4.1. Global Colorectal Cancer Revenue and Growth Rate (2017-2021)
6.5. Cervical Cancer
6.5.1. Global Cervical Cancer Revenue and Growth Rate (2017-2021)
6.6. Lung Cancers
6.6.1. Global Lung Cancers Revenue and Growth Rate (2017-2021)
6.7. Prostate Cancers
6.7.1. Global Prostate Cancers Revenue and Growth Rate (2017-2021)
6.8. Ovarian Cancers
6.8.1. Global Ovarian Cancers Revenue and Growth Rate (2017-2021)
6.9. Others
6.9.1. Global Others Revenue and Growth Rate (2017-2021)
7. Cancer Biopsy Market, By Region
7.1. Introduction
7.2. Global Cancer Biopsy Revenue and Market Share by Regions
7.2.1. Global Cancer Biopsy Revenue by Regions (2017-2021)
7.3. North America Cancer Biopsy by Countries
7.3.1. North America Cancer Biopsy Revenue and Growth Rate (2017-2021)
7.3.2. North America Cancer Biopsy Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Cancer Biopsy by Countries
7.4.1. Europe Cancer Biopsy Revenue and Growth Rate (2017-2021)
7.4.2. Europe Cancer Biopsy Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Cancer Biopsy by Countries
7.5.1. Asia-Pacific Cancer Biopsy Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Cancer Biopsy Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Cancer Biopsy by Countries
7.6.1. South America Cancer Biopsy Revenue and Growth Rate (2017-2021)
7.6.2. South America Cancer Biopsy Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Cancer Biopsy by Countries
7.7.1. Middle East and Africa Cancer Biopsy Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Cancer Biopsy Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Qiagen N.V.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Illumina, Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. ANGLE Plc
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. BD (Becton, Dickinson And Company)
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Myriad Genetics
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Hologic, Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Biocept, Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Thermo Fisher Scientific, Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Danaher
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. F. Hoffmann-La Roche Ltd
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Cancer Biopsy Market Forecast (2022-2027)
9.1. Global Cancer Biopsy Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Cancer Biopsy Market Forecast by Regions (2022-2027)
9.2.1. North America Cancer Biopsy Market Forecast (2022-2027)
9.2.1.1. United States Cancer Biopsy Market Forecast (2022-2027)
9.2.1.2. Canada Cancer Biopsy Market Forecast (2022-2027)
9.2.1.3. Mexico Cancer Biopsy Market Forecast (2022-2027)
9.2.2. Europe Cancer Biopsy Market Forecast (2022-2027)
9.2.2.1. Germany Cancer Biopsy Market Forecast (2022-2027)
9.2.2.2. France Cancer Biopsy Market Forecast (2022-2027)
9.2.2.3. UK Cancer Biopsy Market Forecast (2022-2027)
9.2.2.4. Russia Cancer Biopsy Market Forecast (2022-2027)
9.2.2.5. Italy Cancer Biopsy Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Cancer Biopsy Market Forecast (2022-2027)
9.2.3. Asia-Pacific Cancer Biopsy Market Forecast (2022-2027)
9.2.3.1. China Cancer Biopsy Market Forecast (2022-2027)
9.2.3.2. Japan Cancer Biopsy Market Forecast (2022-2027)
9.2.3.3. Korea Cancer Biopsy Market Forecast (2022-2027)
9.2.3.4. India Cancer Biopsy Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Cancer Biopsy Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Cancer Biopsy Market Forecast (2022-2027)
9.2.4. South America Cancer Biopsy Market Forecast (2022-2027)
9.2.4.1. Brazil Cancer Biopsy Market Forecast (2022-2027)
9.2.4.2. Argentina Cancer Biopsy Market Forecast (2022-2027)
9.2.4.3. Columbia Cancer Biopsy Market Forecast (2022-2027)
9.2.4.4. Rest of South America Cancer Biopsy Market Forecast (2022-2027)
9.2.5. Middle East and Africa Cancer Biopsy Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Cancer Biopsy Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Cancer Biopsy Market Forecast (2022-2027)
9.2.5.3. Egypt Cancer Biopsy Market Forecast (2022-2027)
9.2.5.4. Nigeria Cancer Biopsy Market Forecast (2022-2027)
9.2.5.5. South Africa Cancer Biopsy Market Forecast (2022-2027)
9.2.5.6. Turkey Cancer Biopsy Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Cancer Biopsy Market Forecast (2022-2027)
9.3. Cancer Biopsy Market Forecast by Type (2022-2027)
9.3.1. Cancer Biopsy Forecast by Type (2022-2027)
9.3.2. Cancer Biopsy Market Share Forecast by Type (2022-2027)
9.4. Cancer Biopsy Market Forecast by Applications (2022-2027)
9.4.1. Cancer Biopsy Forecast by Applications (2022-2027)
9.4.2. Cancer Biopsy Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Cancer Biopsy Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Cancer Biopsy Revenue and Revenue Share by Type (2017-2019)
Figure Global Instruments Revenue and Growth Rate (2017-2019)
Figure Global Kits & Consumables Revenue and Growth Rate (2017-2019)
Figure Global Services Revenue and Growth Rate (2017-2019)
Table Global Cancer Biopsy Revenue and Revenue Share by Applications (2017-2019)
Figure Global Breast Cancer Revenue and Growth Rate (2017-2019)
Figure Global Colorectal Cancer Revenue and Growth Rate (2017-2019)
Figure Global Cervical Cancer Revenue and Growth Rate (2017-2019)
Figure Global Lung Cancers Revenue and Growth Rate (2017-2019)
Figure Global Prostate Cancers Revenue and Growth Rate (2017-2019)
Figure Global Ovarian Cancers Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Cancer Biopsy Revenue by Regions (2017-2019)
Figure North America Cancer Biopsy Growth Rate (2017-2019)
Figure North America Cancer Biopsy Revenue and Growth Rate (2017-2019)
Figure North America Cancer Biopsy by Countries (2017-2019)
Figure North America Cancer Biopsy Revenue (Million USD) by Countries (2017-2019)
Figure United States Cancer Biopsy Growth Rate (2017-2019)
Figure United States Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Cancer Biopsy Growth Rate (2017-2019)
Figure Canada Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Cancer Biopsy Growth Rate (2017-2019)
Figure Mexico Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Cancer Biopsy Growth Rate (2017-2019)
Figure Europe Cancer Biopsy Revenue and Growth Rate (2017-2019)
Figure Europe Cancer Biopsy by Countries (2017-2019)
Figure Europe Cancer Biopsy Revenue (Million USD) by Countries (2017-2019)
Figure Germany Cancer Biopsy Growth Rate (2017-2019)
Figure Germany Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Cancer Biopsy Growth Rate (2017-2019)
Figure France Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Cancer Biopsy Growth Rate (2017-2019)
Figure UK Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Cancer Biopsy Growth Rate (2017-2019)
Figure Russia Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Cancer Biopsy Growth Rate (2017-2019)
Figure Italy Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Cancer Biopsy Growth Rate (2017-2019)
Figure Rest of Europe Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Cancer Biopsy Growth Rate (2017-2019)
Figure Asia-Pacific Cancer Biopsy Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Cancer Biopsy by Countries (2017-2019)
Figure Asia-Pacific Cancer Biopsy Revenue (Million USD) by Countries (2017-2019)
Figure China Cancer Biopsy Growth Rate (2017-2019)
Figure China Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Cancer Biopsy Growth Rate (2017-2019)
Figure Japan Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Cancer Biopsy Growth Rate (2017-2019)
Figure Korea Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Cancer Biopsy Growth Rate (2017-2019)
Figure India Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Cancer Biopsy Growth Rate (2017-2019)
Figure Southeast Asia Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Cancer Biopsy Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Cancer Biopsy Growth Rate (2017-2019)
Figure South America Cancer Biopsy Revenue and Growth Rate (2017-2019)
Figure South America Cancer Biopsy by Countries (2017-2019)
Figure South America Cancer Biopsy Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Cancer Biopsy Growth Rate (2017-2019)
Figure Brazil Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Cancer Biopsy Growth Rate (2017-2019)
Figure Argentina Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Cancer Biopsy Growth Rate (2017-2019)
Figure Columbia Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Cancer Biopsy Growth Rate (2017-2019)
Figure Rest of South America Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Cancer Biopsy Growth Rate (2017-2019)
Figure Middle East and Africa Cancer Biopsy Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Cancer Biopsy by Countries (2017-2019)
Figure Middle East and Africa Cancer Biopsy Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Cancer Biopsy Growth Rate (2017-2019)
Figure Saudi Arabia Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Cancer Biopsy Growth Rate (2017-2019)
Figure United Arab Emirates Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Cancer Biopsy Growth Rate (2017-2019)
Figure Egypt Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Cancer Biopsy Growth Rate (2017-2019)
Figure Nigeria Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Cancer Biopsy Growth Rate (2017-2019)
Figure South Africa Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Cancer Biopsy Growth Rate (2017-2019)
Figure Turkey Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Cancer Biopsy Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Cancer Biopsy Revenue (Millions USD) and Growth Rate (2017-2019)
Table Qiagen N.V. Cancer Biopsy Financial Overview
Table Illumina, Inc. Cancer Biopsy Financial Overview
Table ANGLE Plc Cancer Biopsy Financial Overview
Table BD (Becton, Dickinson And Company) Cancer Biopsy Financial Overview
Table Myriad Genetics Cancer Biopsy Financial Overview
Table Hologic, Inc. Cancer Biopsy Financial Overview
Table Biocept, Inc. Cancer Biopsy Financial Overview
Table Thermo Fisher Scientific, Inc. Cancer Biopsy Financial Overview
Table Danaher Cancer Biopsy Financial Overview
Table F. Hoffmann-La Roche Ltd Cancer Biopsy Financial Overview
Figure Global Cancer Biopsy Revenue (Millions USD) and Growth Rate (2019-2027)
Table Cancer Biopsy Market Forecast by Regions (2019-2027)
Figure North America Cancer Biopsy Market Forecast (2019-2027)
Figure United States Cancer Biopsy Market Forecast (2019-2027)
Figure Canada Cancer Biopsy Market Forecast (2019-2027)
Figure Mexico Cancer Biopsy Market Forecast (2019-2027)
Figure Europe Cancer Biopsy Market Forecast (2019-2027)
Figure Germany Cancer Biopsy Market Forecast (2019-2027)
Figure France Cancer Biopsy Market Forecast (2019-2027)
Figure UK Cancer Biopsy Market Forecast (2019-2027)
Figure Russia Cancer Biopsy Market Forecast (2019-2027)
Figure Italy Cancer Biopsy Market Forecast (2019-2027)
Figure Rest of Europe Cancer Biopsy Market Forecast (2019-2027)
Figure Asia-Pacific Cancer Biopsy Market Forecast (2019-2027)
Figure China Cancer Biopsy Market Forecast (2019-2027)
Figure Japan Cancer Biopsy Market Forecast (2019-2027)
Figure Korea Cancer Biopsy Market Forecast (2019-2027)
Figure India Cancer Biopsy Market Forecast (2019-2027)
Figure Southeast Asia Cancer Biopsy Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Cancer Biopsy Market Forecast (2019-2027)
Figure South America Cancer Biopsy Market Forecast (2019-2027)
Figure Brazil Cancer Biopsy Market Forecast (2019-2027)
Figure Argentina Cancer Biopsy Market Forecast (2019-2027)
Figure Columbia Cancer Biopsy Market Forecast (2019-2027)
Figure Rest of South America Cancer Biopsy Market Forecast (2019-2027)
Figure Middle East and Africa Cancer Biopsy Market Forecast (2019-2027)
Figure Saudi Arabia Cancer Biopsy Market Forecast (2019-2027)
Figure United Arab Emirates Cancer Biopsy Market Forecast (2019-2027)
Figure Egypt Cancer Biopsy Market Forecast (2019-2027)
Figure Nigeria Cancer Biopsy Market Forecast (2019-2027)
Figure South Africa Cancer Biopsy Market Forecast (2019-2027)
Figure Turkey Cancer Biopsy Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Cancer Biopsy Market Forecast (2019-2027)
Figure Global Cancer Biopsy Forecast by Type (2019-2027)
Figure Global Cancer Biopsy Market Share Forecast by Type (2019-2027)
Figure Global Cancer Biopsy Forecast by Type (2019-2027)
Figure Global Cancer Biopsy Forecast by Applications (2019-2027)
Figure Global Cancer Biopsy Market Share Forecast by Applications (2019-2027)
Figure Global Cancer Biopsy Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|